The treatment of Alzheimer's Disease & Senile Dementia with vitamins

Alzheimer's Disease and Senile Dementia: Mitamins custom make quality formulas for the treatment of Alzheimer's Disease & Senile Dementia with vitamins. A Alzheimer's Disease & Senile Dementia formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Alzheimer's Disease and Senile Dementia

  • Amount Per Serving
    % DV
    Vitamin C
    200
    mg
    333%
    Vitamin E
    200
    IU
    667%
    Thiamin
    50
    mg
    3333%
    Vitamin B12
    125
    mcg
    2083%
    Flax Seed Powder
    50
    mg
    *
  • Amount Per Serving
    % DV
    Ginkgo Extract
    40
    mg
    *
    Acetyl L-Carnitine
    250
    mg
    *
    Phosphatidylserine
    100
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Alzheimer's Disease and Senile Dementia
Serving Size:4-5

Alzheimer's Disease and Senile Dementia Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Veto Will Deprive Six Million American Children Of Healthcare Services, USA
The American Academy of Child and Adolescent Psychiatry strongly urges Congress to override President Bush's veto of the State Children's Health Insurance Program (H.R. 976) act. The House passed the S-CHIP bill by a 265-159 margin. This vote margin is not large enough to override the President's veto. The Senate passed the measure by a 67-29 margin.
FDA Issues Second Approvable Letter For Trexima?
GlaxoSmithKline (LSE & NYSE: GSK) and POZEN Inc. (NASDAQ: POZN) today announced that the U.S. Food and Drug Administration (FDA) has issued a second approvable letter for Trexima? (sumatriptan/naproxen sodium). An approvable letter is an official notification from the FDA that contains conditions that must be satisfied prior to obtaining final U.S.marketing approval.
This information concerning the support of Alzheimer's Disease and Senile Dementia treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments